PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1970 | 1 |
| 1975 | 1 |
| 1976 | 2 |
| 1982 | 1 |
| 1983 | 1 |
| 1984 | 1 |
| 1986 | 1 |
| 1987 | 3 |
| 1989 | 1 |
| 1990 | 2 |
| 1991 | 1 |
| 1993 | 1 |
| 1995 | 5 |
| 1996 | 1 |
| 1998 | 3 |
| 1999 | 2 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 12 |
| 2006 | 6 |
| 2007 | 25 |
| 2008 | 145 |
| 2009 | 227 |
| 2010 | 211 |
| 2011 | 186 |
| 2012 | 166 |
| 2013 | 116 |
| 2014 | 123 |
| 2015 | 108 |
| 2016 | 116 |
| 2017 | 87 |
| 2018 | 97 |
| 2019 | 113 |
| 2020 | 80 |
| 2021 | 55 |
| 2022 | 64 |
| 2023 | 44 |
| 2024 | 133 |
| 2025 | 105 |
| 2026 | 40 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"J Pharmacol Exp Ther"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Attenuation of the discriminative stimulus and reinforcing effects of positive GABAA modulators after Shisa7 knockdown in rats.
- Morris TM, Henderson AS, Melton SM, Abdurrahman A, Aiyar A, Winsauer PJ.
- J Pharmacol Exp Ther. 2025 Oct 25;392(12):103761. doi: 10.1016/j.jpet.2025.103761.
- PMCID: PMC12799521
Morris TM, et al.J Pharmacol Exp Ther. 2025.PMCID: PMC12799521 -
Acid ceramidase as a novel target for adiponectin receptor agonist to abrogate podocyte NLRP3 inflammasome activation and glomerular inflammation during obesity.
- Li G, Huang D, Kidd JM, Zou Y, Wu X, Zhang Y, Gehr TWB, Li N, Li PL.
- J Pharmacol Exp Ther. 2025 Oct 24;392(12):103757. doi: 10.1016/j.jpet.2025.103757.
- PMCID: PMC13165501
Li G, et al.J Pharmacol Exp Ther. 2025.PMCID: PMC13165501 -
Impact of Δ9-tetrahydrocannabinol and oxycodone coadministration on measures of antinociception, dependence, circadian activity, and reward in mice.
- Slivicki RA, Wang JG, Kucz KV, Hines JF, Tran Nhat VT, Kravitz AV, Creed MC, Gereau RW 4th.
- J Pharmacol Exp Ther. 2026 Aug 14;393(9):105008. doi: 10.1016/j.jpet.2026.105008.
- PMCID: PMC13688984
Slivicki RA, et al.J Pharmacol Exp Ther. 2026.PMCID: PMC13688984 -
US postmarketed drug removals: Analysis of discontinued and withdrawn drugs.
- Bindel LJ, Seifert R.
- J Pharmacol Exp Ther. 2026 Jul 31;393(9):104996. doi: 10.1016/j.jpet.2026.104996.
- PMCID: PMC13688983
Bindel LJ, et al.J Pharmacol Exp Ther. 2026.PMCID: PMC13688983 -
Aryl hydrocarbon receptor as a molecular mediator in the induction of human aldehyde oxidase gene expression.
- Yeap SL, Yap CCL, Tay SH, Zhang LH, Lau AJ.
- J Pharmacol Exp Ther. 2026 Jul 24;393(9):104993. doi: 10.1016/j.jpet.2026.104993.
- PMCID: PMC13688995
Yeap SL, et al.J Pharmacol Exp Ther. 2026.PMCID: PMC13688995 -
M1 muscarinic receptor modulation drives sex-specific alterations of Alzheimer's pathophysiology in APPswe/PSEN1ΔE9 mice.
- Bassiouni W, Ye E, Colson TL, Ferguson SSG, Abd-Elrahman KS.
- J Pharmacol Exp Ther. 2026 Jul 9;393(8):104980. doi: 10.1016/j.jpet.2026.104980.
- PMCID: PMC13688976
Bassiouni W, et al.J Pharmacol Exp Ther. 2026.PMCID: PMC13688976 -
α-Synuclein regulates monoamine transporter capacity and amphetamine-induced efflux via modulation of transporter expression.
- Ludwig I, Moser S, Lukenic M, Connor M, Sofic A, Kaltenbrunner S, Pätzold C, Hausleitner A, Gilbert C, Sucic S, Roblek M, Steinkellner T.
- J Pharmacol Exp Ther. 2026 Jul 4;393(8):104981. doi: 10.1016/j.jpet.2026.104981.
- PMCID: PMC13688989
Ludwig I, et al.J Pharmacol Exp Ther. 2026.PMCID: PMC13688989 -
Factors that influence the conditioned reinforcing effects of a cocaine-associated stimulus.
- Robertson SH, Rysztak LG, Jutkiewicz EM.
- J Pharmacol Exp Ther. 2025 Oct 21;392(12):103754. doi: 10.1016/j.jpet.2025.103754.
- PMCID: PMC12799585
Robertson SH, et al.J Pharmacol Exp Ther. 2025.PMCID: PMC12799585 -
Delta opioid receptor activation influences responding to earn cocaine-associated cues in the New Response Acquisition procedure.
- Rysztak LG, Hoying L, Rice KC, Robertson SH, Jutkiewicz EM.
- J Pharmacol Exp Ther. 2025 Oct 20;392(12):103753. doi: 10.1016/j.jpet.2025.103753.
- PMCID: PMC12799511
Rysztak LG, et al.J Pharmacol Exp Ther. 2025.PMCID: PMC12799511 -
A mu-opioid receptor positive allosteric modulator provides opioid-sparing antinociception without enhancing opioid side effects.
- Kochan KE, Clements BM, Prince TD, Demery C, White AD, Levitt ES, Traynor JR.
- J Pharmacol Exp Ther. Author manuscript. 2026 Feb 18;393(4):104304. doi: 10.1016/j.jpet.2026.104304.
- PMCID: PMC13632509
Kochan KE, et al.J Pharmacol Exp Ther. Author manuscript. 2026.PMCID: PMC13632509